CRIS Current Research Information System

DE PONTI, FABRIZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.213
EU - Europa 9.156
AS - Asia 9.059
AF - Africa 766
SA - Sud America 605
Continente sconosciuto - Info sul continente non disponibili 36
OC - Oceania 31
Totale 31.866
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.089
SG - Singapore 2.928
CN - Cina 2.539
GB - Regno Unito 2.284
IT - Italia 2.264
VN - Vietnam 1.637
DE - Germania 1.140
HK - Hong Kong 782
SE - Svezia 768
UA - Ucraina 539
IN - India 504
RU - Federazione Russa 486
BR - Brasile 456
FR - Francia 323
IE - Irlanda 323
NL - Olanda 272
CI - Costa d'Avorio 225
TG - Togo 216
ZA - Sudafrica 177
KR - Corea 170
JP - Giappone 146
EE - Estonia 144
FI - Finlandia 98
JO - Giordania 83
CA - Canada 78
CH - Svizzera 77
HR - Croazia 73
BG - Bulgaria 72
BE - Belgio 71
AR - Argentina 67
ID - Indonesia 59
AT - Austria 52
SC - Seychelles 48
NG - Nigeria 47
PL - Polonia 42
EU - Europa 34
MX - Messico 30
GR - Grecia 29
EC - Ecuador 26
ES - Italia 26
AU - Australia 23
BD - Bangladesh 21
TR - Turchia 21
LT - Lituania 19
TW - Taiwan 19
UZ - Uzbekistan 19
SA - Arabia Saudita 18
IR - Iran 15
PH - Filippine 15
CL - Cile 14
RO - Romania 14
CO - Colombia 13
CZ - Repubblica Ceca 13
TH - Thailandia 13
EG - Egitto 11
IL - Israele 10
LB - Libano 10
PE - Perù 10
PT - Portogallo 10
DZ - Algeria 9
KE - Kenya 9
MA - Marocco 8
NZ - Nuova Zelanda 8
TN - Tunisia 8
VE - Venezuela 8
AZ - Azerbaigian 6
MY - Malesia 6
PY - Paraguay 6
KZ - Kazakistan 5
AE - Emirati Arabi Uniti 4
BA - Bosnia-Erzegovina 4
IQ - Iraq 4
AL - Albania 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
KH - Cambogia 3
OM - Oman 3
SV - El Salvador 3
UY - Uruguay 3
AM - Armenia 2
BO - Bolivia 2
BW - Botswana 2
HN - Honduras 2
HU - Ungheria 2
JM - Giamaica 2
KG - Kirghizistan 2
KW - Kuwait 2
LK - Sri Lanka 2
PA - Panama 2
PK - Pakistan 2
RS - Serbia 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BF - Burkina Faso 1
CY - Cipro 1
DM - Dominica 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GT - Guatemala 1
Totale 31.852
Salva come PNG Salva come JPEG
Città #
Southend 2.005
Singapore 1.883
Fairfield 1.279
Ashburn 1.111
Chandler 939
Hong Kong 761
Dong Ket 656
Wilmington 622
Woodbridge 574
Seattle 561
Ann Arbor 543
Santa Clara 522
Princeton 493
Houston 483
Hefei 452
Cambridge 431
Bologna 390
Beijing 385
Dublin 315
Boardman 302
Jacksonville 278
Ho Chi Minh City 252
Abidjan 225
Lomé 216
Westminster 187
Hanoi 186
Padova 177
Los Angeles 171
Nanjing 171
Seoul 158
Dallas 150
Berlin 149
Milan 143
Rome 122
Tokyo 121
Buffalo 117
Redmond 115
New York 112
Saint Petersburg 102
San Diego 90
Jinan 89
Amman 83
Turin 83
Medford 76
Shenyang 73
Sofia 72
Bremen 71
Brussels 69
Helsinki 65
Redondo Beach 63
Shanghai 63
Changsha 61
Nanchang 61
Hebei 60
Bern 58
Falls Church 58
Munich 58
Mülheim 58
Florence 57
Verona 51
Guangzhou 50
São Paulo 50
Tianjin 47
Zhengzhou 46
Jiaxing 44
Dearborn 43
London 42
Bengaluru 41
Toronto 39
Abeokuta 38
Des Moines 38
Jakarta 36
Frankfurt am Main 34
The Dalles 34
Chicago 33
Council Bluffs 33
Yubileyny 33
Mahé 31
Redwood City 30
Phoenix 29
Hangzhou 28
Ningbo 28
Vienna 28
Norwalk 27
Olalla 27
Falkenstein 26
Biella 24
Da Nang 24
Modena 24
Bühl 23
Haiphong 22
Wuhan 22
Naples 21
Shenzhen 21
Nuremberg 20
Taipei 19
Taizhou 19
Biên Hòa 18
Kunming 18
Turku 18
Totale 20.506
Salva come PNG Salva come JPEG
Nome #
Interazioni tra sistema serotoninergico e mediatori dell'infiammazione nella fisiopatologia della sindrome dell'intestino irritabile 689
Torsadogenic risk of antipsychotics: combining adverse event reports with drug utilization data across Europe. 469
Adverse events with sodium-glucose co-transporter-2 inhibitors: A global analysis of international spontaneous reporting systems 295
Data Mining Techniques in Pharmacovigilance: Analysis of the Publicly Accessible FDA Adverse Event Reporting System (AERS) 276
Adverse events with sacubitril/valsartan in the real world: emerging signals to target preventive strategies from the FDA adverse event reporting system 273
Escherichia coli Nissle 1917 restores epithelial permeability alterations induced by irritable bowel syndrome mediators 265
Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage 241
Adverse cardiovascular events associated with triptans and ergotamines for treatment of migraine: Systematic review of observational studies 233
hERG-related drug toxicity and models for predicting hERG liability and QT prolongation 232
Appropriateness of Proton Pump Inhibitor (PPI) prescription in patients admitted to hospital: Attitudes of general practitioners and hospital physicians in Italy 231
Biomarkers of Kidney Injury in Very-low-birth-weight Preterm Infants: Influence of Maternal and Neonatal Factors 231
Diagnosis and therapy of irritable bowel syndrome 226
Adverse Events to Food Supplements Containing Red Yeast Rice: Comparative Analysis of FAERS and CAERS Reporting Systems 226
Elementi di Farmacologia: Compendio per l’esame. 221
Adopting STOPP/START Criteria Version 3 in Clinical Practice: A Q&A Guide for Healthcare Professionals 219
Farmacologia. Azioni e Reazioni dei farmaci. 213
Antibacterial macrolides: a drug class with a complex pharmacological profile 209
Advancements in drug development for diarrhea-predominant irritable bowel syndrome 205
beta3-adrenoceptors in the gut: evidence for a possible role in enteric neuroimmunomodulation 203
Prescriptions of antidepressants in primary care in Italy: pattern of use after admission of selective serotonin reuptake inhibitors for reimbursement 198
Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage. 196
Anticancer drugs and cardiotoxicity: Insights and perspectives in the era of targeted therapy. 196
Antipsychotics and Torsadogenic Risk: Signals Emerging from the US FDA Adverse Event Reporting System Database. 196
Predictors of antipsychotic prescription in a Northern Italian District (Bologna) 191
Animal models of chemically induced intestinal inflammation: Predictivity and ethical issues 189
Colonic mucosal mediators from patients with irritable bowel syndrome excite enteric cholinergic motor neurons 189
Switching among Equivalents in Chronic Cardiovascular Therapies: 'Real World' Data from Italy 187
Impulse Control Disorders by Dopamine Partial Agonists: A Pharmacovigilance-Pharmacodynamic Assessment Through the FDA Adverse Event Reporting System 185
Dipeptidyl peptidase-4 inhibitors and heart failure: Analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System 185
Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System 184
Antimicrobials and the Risk of Torsades de Pointes. The Contribution from Data Mining of the US FDA Adverse Event Reporting System 183
Nerve fiber outgrowth is increased in the intestinal mucosa of patients with irritable bowel syndrome 183
Severe quetiapine voluntary overdose successfully treated with a new hemoperfusion sorbent 181
Adverse events associated with the use of direct-acting oral anticoagulants in clinical practice: beyond bleeding complications 179
Addition of dipeptidyl peptidase-4 inhibitors to sulphonylureas and risk of hypoglycaemia: systematic review and meta-analysis 177
Therapeutic innovation in the European Union: analysis of the drugs approved by the EMEA between 1995 and 2003. 174
An update on the first decade of the European centralized procedure: how many innovative drugs? 174
Assessing liver injury associated with antimycotics: Concise literature review and clues from data mining of the FAERS database 173
Pattern of drug use among preterm neonates: Results from an Italian neonatal intensive care unit 172
Multiple sclerosis as an adverse drug reaction: clues from the FDA Adverse Event Reporting System 172
Altered Serotonin Signaling and Extrinsic Sensory Neuron Activation in Irritable Bowel Syndrome 171
Paraneoplastic Syndrome 168
Cardiovascular events in statin recipients: impact of adherence to treatment in a 3-year record linkage study 168
Social and clinical descriptors of antipsychotic prescription 166
Occurrence of Multiple Sclerosis After Drug Exposure: Insights From Evidence Mapping 166
The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project 166
Risk of hospitalization from drug-drug interactions in the Elderly: real-world evidence in a large administrative database 166
Myocarditis and pericarditis after immunization: Gaining insights through the Vaccine Adverse Event Reporting System 165
Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome. 164
Clinically important drug-drug interactions in poly-treated elderly outpatients: A campaign to improve appropriateness in general practice 164
Posterior Reversible Encephalopathy Syndrome Associated With Licorice Consumption: A Case Report in a 10-Year-Old Boy 163
Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System 160
Neuroplasticity of the enteric nervous system induced by inflammatory conditions in the gut 160
Drug-induced renal injury in neonates: challenges in clinical practice and perspectives in drug development 160
Disproportionality signal of progressive multifocal leukoencephalopathy: monoclonal antibodies versus other immunosuppressants 159
Detection of D-penicillamine in skin lesions in a case of dermal elastosis after a previous long-term treatment for Wilson's disease 159
Academic output from EU-funded health research projects 157
5-HT7 Receptors Modulate Peristalsis and Accommodation in the Guinea Pig Ileum 157
Drug-induced Kounis syndrome: A matter of pharmacovigilance 157
Hepatitis B vaccination and the putative risk of central demyelinating diseases - A systematic review and meta-analysis 156
Pro-arrhythmic potential of oral antihistamines (H1): Combining adverse event reports with drug utilization data across Europe 156
Non-peptidyl low molecular weight radical scavenger IAC attenuates DSS-induced colitis in rats. 155
Effects of the non-peptidyl low molecular weight radical scavenger IAC in DNBS-induced colitis in rats. 155
Case Report. 155
Protection from DNBS-induced colitis by the tachykinin NK1 receptor antagonist SR140333 in rats 154
Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics 153
Aspetti clinici ed anticorpi anti-neurone nella malattia celiaca con disordini neurologici 153
Delayed gastric emptying in functional dyspepsia 151
Drug-Induced Renal Damage in Preterm Neonates: State of the Art and Methods for Early Detection 151
Human papillomavirus vaccine and demyelinating diseases-A systematic review and meta-analysis 151
Ceftolozane/tazobactam exposure in critically ill patients undergoing continuous renal replacement therapy: a PK/PD approach to tailor dosing 149
Use of phytoestrogens and effects perceived by postmenopausal women: result of a questionnaire-based survey 148
Evaluating sacubitril/valsartan as a treatment option for heart failure with reduced ejection fraction and preserved ejection fraction 148
Amyotrophic Lateral Sclerosis as an Adverse Drug Reaction: A Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System 147
Effect of muscarinic receptor blockade on canine gastric tone and compliance in vivo 146
La condivisione dei trattamenti farmacologici in psichiatria e la percezione degli effetti avversi ai farmaci antipisicotici da medico, paziente e familiare 146
Exploring the underlying mechanisms of drug-induced impulse control disorders: a pharmacovigilance-pharmacodynamic study 145
Long-acting injectable antipsychotics: Six-month follow-up of new outpatient treatments in Bologna Community Mental Health Centres 144
Dapagliflozin and cardiovascular outcomes: anything else to DECLARE? 144
Targeting the arrhythmogenic substrate in atrial fibrillation: focus on structural remodeling 142
Serotonin receptor modulators 141
Farmaci lassativi e purganti 141
Inflammatory neuropathies of the enteric nervous system 141
Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from Pharmacovigilance 141
Excipients in medicinal products used in gastroenterology as a possible cause of side effects. 140
Mesenchymal stromal cell-based therapy: Regulatory and translational aspects in gastroenterology 140
Strategies and Tools for Supporting the Appropriateness of Drug Use in Older People 139
A clinical pharmacology and therapeutics teacher's guide to race-based medicine, inclusivity, and diversity 138
QT interval shortening in spontaneous reports submitted to the FDA: the need for consensus 138
Recurrence of pericarditis after influenza vaccination: a case report and review of the literature 136
Antimicrobial-induced torsades de pointes: towards risk stratification by data mining of the FDA Adverse Event Reporting System. 135
Use of antihistamines and risk of ventricular tachyarrhythmia: a nested case-control study in five European countries from the ARITMO project. 135
Cyclin-dependent kinase 4/6 inhibitors and interstitial lung disease in the FDA adverse event reporting system: a pharmacovigilance assessment 135
Using artificial intelligence to create diverse and inclusive medical case vignettes for education 134
L'essenziale in Farmacologia Clinica 133
Gastro-intestinal problems and concomitant medication in NSAID users: additional findings from a questionnaire-based survey in Italy 133
Enteric neuroplasticity evoked by inflammation 133
The hERG K+ channel: target and antitarget strategies in drug development. 133
Cardiovascular toxicity of anticancer-targeted therapy: emerging issues in the era of cardio-oncology. 133
Pattern of NSAID use in the Italian general population: a questionnaire-based survey. 133
Totale 17.998
Salva come PNG Salva come JPEG
Categoria #
all - tutte 93.771
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 93.771
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.205 0 0 0 0 0 253 90 202 265 180 209 1.006
2021/20224.483 556 147 257 225 361 275 185 276 176 228 1.084 713
2022/20234.512 446 555 300 564 309 314 211 286 764 194 388 181
2023/20241.573 129 218 141 167 151 239 67 116 54 113 105 73
2024/20255.333 296 866 619 296 843 319 349 202 142 316 172 913
2025/20266.143 955 1.093 1.206 844 1.429 616 0 0 0 0 0 0
Totale 32.485